Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Abstract

Treating leukocytoclastic vasculitis associated with etanercept therapy. Is it necessary to stop etanercept?

Antonio Juan, Bartolome Ribas, Cristina Nadal and Imnaculada Ros
The Journal of Rheumatology October 2005, 32 (10) 2061;
Antonio Juan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bartolome Ribas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cristina Nadal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Imnaculada Ros
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Article Information

vol. 32 no. 10 2061
PubMed 
16206372

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752


Author Information

Article usage

Article usage: March 2009 to July 2026

AbstractFullPdf
Mar 2009002
Apr 2009002
Jun 2009005
Aug 2009005
Sep 2009002
Oct 2009004
Nov 2009004
Dec 2009002
Jan 2010002
Mar 2010003
Apr 2010001
Jun 2010008
Jul 2010003
Sep 2010006
Oct 2010003
Nov 2010007
Dec 2010004
Jan 20110012
Feb 2011004
Mar 20110016
Apr 2011003
May 2011003
Jun 2011001
Jul 20110011
Aug 2011002
Sep 2011001
Oct 20110010
Nov 2011003
Dec 2011007
Jan 20120011
Feb 2012003
Mar 2012003
Apr 2012008
May 2012002
Jun 2012006
Jul 2012006
Aug 2012004
Sep 2012004
Oct 2012003
Nov 2012004
Dec 2012005
Jan 20130012
Feb 20130010
Mar 20130012
Apr 2013005
May 2013008
Jun 2013007
Jul 2013004
Aug 2013004
Sep 2013004
Oct 2013003
Nov 2013009
Jan 2014003
Apr 2014002
May 2014003
Jun 2014003
Jul 2014005
Aug 2014004
Sep 2014004
Oct 2014003
Nov 2014003
Dec 2014001
Jan 2015005
Feb 2015003
Mar 2015103
Apr 2015002
May 2015003
Jun 2015006
Jul 20150012
Sep 2015001
Oct 2015007
Dec 2015001
Jan 20160043
Feb 2016008
Mar 2016003
Apr 2016005
May 2016006
Jun 2016006
Jul 20160111
Aug 20160017
Sep 20160010
Oct 20160113
Nov 20160110
Dec 2016008
Jan 2017002
Feb 2017003
Mar 2017002
Apr 2017001
May 2017001
Jun 2017004
Jul 2017003
Sep 2017006
Oct 2017003
Nov 2017002
Dec 2017002
Jan 2018003
Feb 2018003
Mar 2018002
Apr 2018006
May 2018009
Jun 2018008
Jul 2018006
Sep 2018002
Oct 2018003
Nov 2018001
Dec 2018002
Jan 2019002
Feb 2019006
Mar 2019001
Apr 2019002
May 2019002
Jun 2019002
Jul 2019001
Aug 2019003
Oct 2019003
Nov 2019006
Dec 2019001
Jan 2020001
Feb 2020001
Mar 2020001
Apr 2020002
May 2020001
Jun 2020001
Jul 2020004
Aug 2020002
Sep 2020002
Oct 2020003
Nov 2020001
Dec 2020001
Jan 2021002
Feb 2021001
Mar 2021001
Apr 2021005
May 2021001
Jun 2021002
Sep 2021005
Oct 2021005
Nov 2021007
Dec 2021002
Apr 2022002
May 2022005
Jul 2022001
Aug 2022003
Oct 2022001
Nov 2022002
Jan 20230010
Mar 2023004
May 2023006
Jul 2023004
Aug 2023003
Sep 2023005
Nov 2023005
Dec 2023004
Mar 2024002
Apr 2024006
Jun 2024002
Aug 2024002
Sep 2024005
Oct 2024004
Nov 2024004
Dec 2024002
Jan 2025004
Feb 2025002
Mar 2025001
Apr 2025001
May 2025001
Jun 2025007
Jul 2025005
Aug 20250013
Sep 2025006
Oct 2025005
Nov 2025004
Dec 2025003
Jan 2026001
Feb 2026004
Mar 2026007
Apr 20260018
May 2026008
Jun 20260011
Jul 20260018

Statistics from Altmetric.com

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 32, Issue 10
1 Oct 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Treating leukocytoclastic vasculitis associated with etanercept therapy. Is it necessary to stop etanercept?
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Treating leukocytoclastic vasculitis associated with etanercept therapy. Is it necessary to stop etanercept?
Antonio Juan, Bartolome Ribas, Cristina Nadal, Imnaculada Ros
The Journal of Rheumatology Oct 2005, 32 (10) 2061;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Treating leukocytoclastic vasculitis associated with etanercept therapy. Is it necessary to stop etanercept?
Antonio Juan, Bartolome Ribas, Cristina Nadal, Imnaculada Ros
The Journal of Rheumatology Oct 2005, 32 (10) 2061;
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire